Skip to main content
Top
Published in: Breast Cancer Research 3/2009

Open Access 01-06-2009 | Research article

A constant risk for familial breast cancer? A population-based family study

Authors: Kamila Czene, Marie Reilly, Per Hall, Mikael Hartman

Published in: Breast Cancer Research | Issue 3/2009

Login to get access

Abstract

Introduction

The incidence of breast cancer in the unaffected breast of women with previous breast malignancy remains constant after the first diagnosis. We investigated whether there is a similar pattern in the breast cancer incidence in first-degree relatives of breast cancer patients. We studied the risk for breast cancer in mothers at ages older than their daughter's age at diagnosis.

Methods

We analyzed a Swedish population-based cohort with complete family links and calculated incidence rates of breast cancer in mothers of 48,259 daughters diagnosed with breast cancer.

Results

The risk for breast cancer in mothers of breast cancer patients is elevated relative to the background population at all ages. Mothers have an overall incidence of 0.34%/year at ages older than a daughter's age at diagnosis. This rate is not affected to any large extent by the daughter's age at diagnosis. A constant incidence rate of 0.40%/year from age 35 years onward is seen in mothers of breast cancer patients diagnosed before 35 years of age. For mothers of daughters diagnosed at age 35 to 44 years the incidence pattern is less clear, with the rate being stable for approximately 20 years after the daughter's age at diagnosis and rising thereafter. Older age at a daughter's diagnosis (≥ 45 years) appears to confer an age-dependent increase in incidence in the mother.

Conclusions

Incidence of familial breast cancer in first-degree relatives may increase to a high and constant level by a predetermined age that is specific to each family. This phenomenon appears inconsistent with accepted theories of malignant transformation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hemminki K, Li X, Czene K: Cancer risks in first-generation immigrants to Sweden. Int J Cancer. 2002, 99: 218-228. 10.1002/ijc.10322.CrossRefPubMed Hemminki K, Li X, Czene K: Cancer risks in first-generation immigrants to Sweden. Int J Cancer. 2002, 99: 218-228. 10.1002/ijc.10322.CrossRefPubMed
2.
go back to reference Colditz GA, Rosner B: Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol. 2000, 152: 950-964. 10.1093/aje/152.10.950.CrossRefPubMed Colditz GA, Rosner B: Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol. 2000, 152: 950-964. 10.1093/aje/152.10.950.CrossRefPubMed
3.
go back to reference Hemminki K, Granstrom C, Czene K: Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden. Int J Cancer. 2002, 100: 214-219. 10.1002/ijc.10467.CrossRefPubMed Hemminki K, Granstrom C, Czene K: Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden. Int J Cancer. 2002, 100: 214-219. 10.1002/ijc.10467.CrossRefPubMed
4.
go back to reference Antoniou AC, Pharoah PP, Smith P, Easton DF: The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer. 2004, 91: 1580-1590.PubMedPubMedCentral Antoniou AC, Pharoah PP, Smith P, Easton DF: The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer. 2004, 91: 1580-1590.PubMedPubMedCentral
5.
go back to reference Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL: Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst. 1997, 89: 287-293. 10.1093/jnci/89.4.287.CrossRefPubMed Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL: Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst. 1997, 89: 287-293. 10.1093/jnci/89.4.287.CrossRefPubMed
6.
go back to reference Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000, 343: 78-85. 10.1056/NEJM200007133430201.CrossRefPubMed Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000, 343: 78-85. 10.1056/NEJM200007133430201.CrossRefPubMed
7.
go back to reference Czene K, Lichtenstein P, Hemminki K: Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer. 2002, 99: 260-266. 10.1002/ijc.10332.CrossRefPubMed Czene K, Lichtenstein P, Hemminki K: Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer. 2002, 99: 260-266. 10.1002/ijc.10332.CrossRefPubMed
8.
go back to reference Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001, 358: 1389-1399. 10.1016/S0140-6736(01)06524-2.CrossRef Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001, 358: 1389-1399. 10.1016/S0140-6736(01)06524-2.CrossRef
9.
go back to reference Hemminki K, Vaittinen P: Familial cancers in a nationwide family cancer database: age distribution and prevalence. Eur J Cancer. 1999, 35: 1109-1117. 10.1016/S0959-8049(99)00066-0.CrossRefPubMed Hemminki K, Vaittinen P: Familial cancers in a nationwide family cancer database: age distribution and prevalence. Eur J Cancer. 1999, 35: 1109-1117. 10.1016/S0959-8049(99)00066-0.CrossRefPubMed
10.
go back to reference Peto J, Mack TM: High constant incidence in twins and other relatives of women with breast cancer. Nat Genet. 2000, 26: 411-414. 10.1038/82533.CrossRefPubMed Peto J, Mack TM: High constant incidence in twins and other relatives of women with breast cancer. Nat Genet. 2000, 26: 411-414. 10.1038/82533.CrossRefPubMed
11.
go back to reference Olsen JH, Seersholm N, Boice JD, Kruger Kjaer S, Fraumeni JF: Cancer risk in close relatives of women with early-onset breast cancer: a population-based incidence study. Br J Cancer. 1999, 79: 673-679. 10.1038/sj.bjc.6690106.CrossRefPubMedPubMedCentral Olsen JH, Seersholm N, Boice JD, Kruger Kjaer S, Fraumeni JF: Cancer risk in close relatives of women with early-onset breast cancer: a population-based incidence study. Br J Cancer. 1999, 79: 673-679. 10.1038/sj.bjc.6690106.CrossRefPubMedPubMedCentral
12.
go back to reference Rebora P, Czene K, Reilly M: Timing of familial breast cancer in sisters. J Natl Cancer Inst. 2008, 100: 721-7. 10.1093/jnci/djn146.CrossRefPubMed Rebora P, Czene K, Reilly M: Timing of familial breast cancer in sisters. J Natl Cancer Inst. 2008, 100: 721-7. 10.1093/jnci/djn146.CrossRefPubMed
13.
go back to reference Hemminki K, Vaittinen P: Familial breast cancer in the family-cancer database. Int J Cancer. 1998, 77: 386-391. 10.1002/(SICI)1097-0215(19980729)77:3<386::AID-IJC13>3.0.CO;2-6.CrossRefPubMed Hemminki K, Vaittinen P: Familial breast cancer in the family-cancer database. Int J Cancer. 1998, 77: 386-391. 10.1002/(SICI)1097-0215(19980729)77:3<386::AID-IJC13>3.0.CO;2-6.CrossRefPubMed
14.
go back to reference Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P: Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol. 2005, 6: 377-382. 10.1016/S1470-2045(05)70174-1.CrossRefPubMed Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P: Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol. 2005, 6: 377-382. 10.1016/S1470-2045(05)70174-1.CrossRefPubMed
15.
go back to reference Chen Y, Thompson W, Semenciw R, Mao Y: Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999, 8: 855-861.PubMed Chen Y, Thompson W, Semenciw R, Mao Y: Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999, 8: 855-861.PubMed
16.
go back to reference Chen Y, Semenciw R, Kliewer E, Shi Y, Mao Y: Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada. Breast Cancer Res Treat. 2001, 67: 35-40. 10.1023/A:1010665603732.CrossRefPubMed Chen Y, Semenciw R, Kliewer E, Shi Y, Mao Y: Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada. Breast Cancer Res Treat. 2001, 67: 35-40. 10.1023/A:1010665603732.CrossRefPubMed
17.
go back to reference Hartman M, Hall P, Edgren G, Reilly M, Lindstrom L, Lichtenstein P, Kaprio J, Skytthe A, Peto J, Czene K: Breast cancer onset in twins and women with bilateral disease. J Clin Oncol. 2008, 26: 4086-4091. 10.1200/JCO.2007.14.3198.CrossRefPubMed Hartman M, Hall P, Edgren G, Reilly M, Lindstrom L, Lichtenstein P, Kaprio J, Skytthe A, Peto J, Czene K: Breast cancer onset in twins and women with bilateral disease. J Clin Oncol. 2008, 26: 4086-4091. 10.1200/JCO.2007.14.3198.CrossRefPubMed
18.
go back to reference Multi-Generation Register 2003: A Description of Contents and Quality [in Swedish]. Sweden: Statistics. 2004, Statistics Sweden, Publication Services, SE-701 89 Örebro, Sweden, 7- Multi-Generation Register 2003: A Description of Contents and Quality [in Swedish]. Sweden: Statistics. 2004, Statistics Sweden, Publication Services, SE-701 89 Örebro, Sweden, 7-
19.
go back to reference Mattsson B, Wallgren A: Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984, 23: 305-313. 10.3109/02841868409136026.CrossRefPubMed Mattsson B, Wallgren A: Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984, 23: 305-313. 10.3109/02841868409136026.CrossRefPubMed
20.
go back to reference SAS Institute Inc: SAS/STAT User's Guide. Version 8.2. 1999, Cary, NC: SAS Institute Inc SAS Institute Inc: SAS/STAT User's Guide. Version 8.2. 1999, Cary, NC: SAS Institute Inc
21.
go back to reference Hemminki K, Li X, Plna K, Granström C, Vaittinen P: The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol. 2001, 40: 772-777. 10.1080/02841860152619214.CrossRefPubMed Hemminki K, Li X, Plna K, Granström C, Vaittinen P: The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol. 2001, 40: 772-777. 10.1080/02841860152619214.CrossRefPubMed
22.
go back to reference Leu M, Czene K, Reilly M: The impact of truncation and missing family links in population-based registers on familial risk estimates. Am J Epidemiol. 2007, 166: 1461-1467. 10.1093/aje/kwm234.CrossRefPubMed Leu M, Czene K, Reilly M: The impact of truncation and missing family links in population-based registers on familial risk estimates. Am J Epidemiol. 2007, 166: 1461-1467. 10.1093/aje/kwm234.CrossRefPubMed
23.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001, 94: 153-156. 10.1002/ijc.1440.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001, 94: 153-156. 10.1002/ijc.1440.CrossRefPubMed
24.
go back to reference Globocan 2000: Cancer Incidence, Mortality and Prevelance Worldwide, version 1.0. Volume IARC CancerBase No 5. 2001, Lyon, France: IARC Press Globocan 2000: Cancer Incidence, Mortality and Prevelance Worldwide, version 1.0. Volume IARC CancerBase No 5. 2001, Lyon, France: IARC Press
25.
go back to reference Antoniou AC, Pharoah PD, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF: A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer. 2002, 86: 76-83. 10.1038/sj.bjc.6600008.CrossRefPubMedPubMedCentral Antoniou AC, Pharoah PD, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF: A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer. 2002, 86: 76-83. 10.1038/sj.bjc.6600008.CrossRefPubMedPubMedCentral
26.
go back to reference Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Hamann U, Justenhoven C, Brauch H, Chang-Claude J, Kropp S, et al: A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet. 2007, 39: 352-358. 10.1038/ng1981.CrossRefPubMed Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Hamann U, Justenhoven C, Brauch H, Chang-Claude J, Kropp S, et al: A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet. 2007, 39: 352-358. 10.1038/ng1981.CrossRefPubMed
27.
go back to reference Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007, 447: 1087-1093. 10.1038/nature05887.CrossRefPubMedPubMedCentral Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007, 447: 1087-1093. 10.1038/nature05887.CrossRefPubMedPubMedCentral
28.
go back to reference Einarsdottir K, Humphreys K, Bonnard C, Palmgren J, Iles MM, Sjolander A, Li Y, Chia KS, Liu ET, Hall P, Liu J, Wedren S: Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk. PLoS Med. 2006, 3: e168-10.1371/journal.pmed.0030168.CrossRefPubMedPubMedCentral Einarsdottir K, Humphreys K, Bonnard C, Palmgren J, Iles MM, Sjolander A, Li Y, Chia KS, Liu ET, Hall P, Liu J, Wedren S: Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk. PLoS Med. 2006, 3: e168-10.1371/journal.pmed.0030168.CrossRefPubMedPubMedCentral
Metadata
Title
A constant risk for familial breast cancer? A population-based family study
Authors
Kamila Czene
Marie Reilly
Per Hall
Mikael Hartman
Publication date
01-06-2009
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 3/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2260

Other articles of this Issue 3/2009

Breast Cancer Research 3/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine